Xiangyu Medical Announces Grant of Invention Patent for 'An Inflation and Deflation Control Method, Device, and Medium for Therapeutic Apparatus'

(Source:Sunnyou Medical）

Source: Sunnyou Medical

Introduction to Invention Patent

A Method, Device, and Medium for Controlling Inflation and Deflation of a Therapy Instrument

Traditional air wave therapy devices mainly work by using an air pump to inflate the cuffs in real time, applying pressure to the limbs through periodic inflation and deflation to promote blood circulation and prevent deep vein thrombosis, among other things. However, this direct inflation method has two significant drawbacks: poor user experience and insufficient precision in air pressure control.

Based on this, the core of this patent is the design of a phased intelligent control strategy, achieving precise inflation schemes. This invention patent provides a progressive air wave therapy technology. During the treatment process, the air pressure gradually increases to the set value in a progressive manner, allowing patients to adapt gradually. Before the end of the treatment, the pressure is gradually reduced to zero, helping to restore steadily.

In addition, this solution innovatively introduces real-time monitoring, tracking the patient's blood oxygen, heart rate, pulse rate, and venous refill time throughout the process. The device can intelligently adjust pressure to achieve stepwise treatment, and once beyond the safety threshold, it can smartly issue warnings and stop operation. This design enhances treatment tolerance, especially for patient groups with poor tolerance, making rehabilitation treatment more reassuring.

The application of this invention patent not only optimizes equipment performance and portability, enhances the treatment experience, but also addresses inherent defects of traditional medical devices, promoting technological integration and intelligent development.

As of now, Sunnyou Medical has been granted effective patents.More than 2,000 items。In the future, the company will continue to focus on technological innovation as its core.Driving Force，Continuously increase R&D investment, continuously enhance core competitiveness through technological iteration, and provide solid support for the high-quality development of enterprises.